e-learning
resources
Munich 2014
Sunday, 07.09.2014
Lung cell biology in injury and repair
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The synthetic
streptococcus pneumoniae
oligosaccharide conjugate protected mice from severe pneumonia
K. Reppe, C. Anish, R. Bell, S. G. Parameswarappa, S. Govindan, C. L. Pereira, K. Dietert, L. E. Sander, A. D. Gruber, N. Suttorp, P. H. Seeberger, M. Witzenrath (Berlin, Potsdam, Germany)
Source:
International Congress 2014 – Lung cell biology in injury and repair
Session:
Lung cell biology in injury and repair
Session type:
Thematic Poster Session
Number:
889
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Reppe, C. Anish, R. Bell, S. G. Parameswarappa, S. Govindan, C. L. Pereira, K. Dietert, L. E. Sander, A. D. Gruber, N. Suttorp, P. H. Seeberger, M. Witzenrath (Berlin, Potsdam, Germany). The synthetic
streptococcus pneumoniae
oligosaccharide conjugate protected mice from severe pneumonia. Eur Respir J 2014; 44: Suppl. 58, 889
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Monitoring of antimicrobial resistance respiratory strains of streptococcus pneumoniae
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Efficacy of Ceftolozane/Tazobactam in Comparison with Piperacillin/Tazobactam in Severe Pseudomonas aeruginosa Pneumonia Swine Model
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Development of an antibody therapy for the treatment of pneumonia
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Pseudomonas aeruginosa
pneumonia in the community
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Relation between bacteremia and septic shock in patients with pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Aerobic exercise inhibits pseudomonas aeruginosa-induced acute lung injury in elderly mice
Source: International Congress 2014 – Immunology of respiratory infections
Year: 2014
Evolutionary trend of invasive pneumococcal disease according to serotypes
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Neutralizing the complement component C5a protects against lung injury and extrapulmonary organ injury in pneumococcal pneumonia induced sepsis
Source: International Congress 2014 – Critical illness and therapeutic interventions
Year: 2014
Ventilator-Induced Lung Injury Increases Systemic Inflammation in Murine Pseudomonas Aeruginosa Pneumonia
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019
Emerging macrolide-resistant
mycoplasma pneumoniae
in Thailand
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Modern etiology of severe community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013
Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Impact of nasopharyngeal pneumococcal colonization on dendritic cell-dependent protective immunity against invasive pneumococcal disease in mice
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Modification of empirical antibiotic therapy in community acquired pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Cavitary bacterial lung infections – Predictive factors and outcomes
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Chronic pulmonary infection with streptococcus pneumoniae during ovalbumin allergic inflammation
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept